XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 226,231
Notes receivable, net 163,588
Prepaid expenses and other receivable 37,418 44,085
Total Current Assets 37,418 433,904
Prepayment for acquisition-related party 145,000
TOTAL ASSETS 37,418 578,904
Current Liabilities:    
Accounts payable and accrued liabilities 855,991 233,378
Convertible notes payable, net of debt discount of $0 471,094
Total Current Liabilities 1,327,085 233,378
Total Liabilities 1,327,085 233,378
Commitments and contingencies
Stockholders’ Equity    
Preferred stock: 15,000,000 authorized; $0.01 par value; Series A Convertible Preferred stock: 15,000,000 designated, 0 shares issued and outstanding
Common stock: 10,000,000,000 authorized; $0.001 par value; 3,105,704,056 and 2,693,190,084 shares issued and outstanding, respectively 3,105,704 2,693,190
Additional paid in capital 25,394,278 24,135,367
Shares to be issued 531,000 576,000
Accumulated deficit (30,320,649) (27,059,031)
Total Stockholders’ Equity (1,289,667) 345,526
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 37,418 $ 578,904